<SEC-DOCUMENT>0001125345-23-000021.txt : 20230214
<SEC-HEADER>0001125345-23-000021.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230213181239
ACCESSION NUMBER:		0001125345-23-000021
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230213
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		23620638

	BUSINESS ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mgnx-20230213.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:d8e94095-42fb-4d36-a78d-ecdd0d27872f,g:2229d6f8-a959-48ea-859e-69cdf90cdf26,d:dac2edc8e1fb4278a30372d00eb431f8--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20230213</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF80L2ZyYWc6YTk0ZmQ4ZTQ2MWM5NDNjOWEzOWFkMzlhNGFkNWNjYTEvdGFibGU6ZDQxMDdiNzljNGE2NDExNGEyMjUzMDJlOGIzYjY0MmEvdGFibGVyYW5nZTpkNDEwN2I3OWM0YTY0MTE0YTIyNTMwMmU4YjNiNjQyYV8yLTEtMS0xLTYyMjEz_086c52a3-363b-47b1-9669-79cabbce70fc">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF80L2ZyYWc6YTk0ZmQ4ZTQ2MWM5NDNjOWEzOWFkMzlhNGFkNWNjYTEvdGFibGU6ZDQxMDdiNzljNGE2NDExNGEyMjUzMDJlOGIzYjY0MmEvdGFibGVyYW5nZTpkNDEwN2I3OWM0YTY0MTE0YTIyNTMwMmU4YjNiNjQyYV8zLTEtMS0xLTYyMjEz_acfee689-251f-4f1f-8ebe-0ba01ef6e6ba">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20230213.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-13</xbrli:startDate><xbrli:endDate>2023-02-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="idac2edc8e1fb4278a30372d00eb431f8_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xMDY_60caa835-3657-458a-b6e6-043c09ee01c9">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjYw_fd9536ac-c271-499e-bce5-85b470c23046">February 13, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8yNzA_84cdc960-16e5-4fdb-833f-4301b9920340">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6M2IwZDVlNTNkZTMzNDA0NDgzMTQyOWExN2EzZTUzYTgvdGFibGVyYW5nZTozYjBkNWU1M2RlMzM0MDQ0ODMxNDI5YTE3YTNlNTNhOF8wLTAtMS0xLTYyMjEz_38d06fe4-b122-403d-93c4-64277812102c">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6M2IwZDVlNTNkZTMzNDA0NDgzMTQyOWExN2EzZTUzYTgvdGFibGVyYW5nZTozYjBkNWU1M2RlMzM0MDQ0ODMxNDI5YTE3YTNlNTNhOF8wLTEtMS0xLTYyMjEz_4fbe6afa-c2d7-4cef-92e1-355ccce043bf">001-36112</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6M2IwZDVlNTNkZTMzNDA0NDgzMTQyOWExN2EzZTUzYTgvdGFibGVyYW5nZTozYjBkNWU1M2RlMzM0MDQ0ODMxNDI5YTE3YTNlNTNhOF8wLTItMS0xLTYyMjEz_4fcea4b9-ea03-4ea2-b2cb-9397d0bb7fd8">06-1591613</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Identification No.)</span></div></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:23.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt;padding-right:24.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8wLTAtMS0yLTYyMjEz_946177e7-dbc8-4eb4-a5cd-e5667e9b9974">9704 Medical Center Drive</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8xLTAtMS0xLTYyMjEz_db96e6e4-3359-4e5d-b98f-7d4227406a7e">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8xLTEtMS0xLTYyMjEz_9538eb9f-9d22-45fc-9bb7-420acfaf8d6a">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8xLTMtMS0xLTYyMjEz_03889c68-9779-4b93-b571-980319e11e41">20850</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8zODY_76d73a1e-8530-483c-990f-3b93dc954f01">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8zOTA_0177da95-169a-4b44-beb6-55776ad9facc">251-5172</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.051%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6ZTVlNzI4MzY3OGU5NDM3Mjg1MmIxODhhZTFmODhmYWQvdGFibGVyYW5nZTplNWU3MjgzNjc4ZTk0MzcyODUyYjE4OGFlMWY4OGZhZF8zLTAtMS0xLTYyMjEz_37521054-3c37-4a57-9209-698f761d28e3">Common Stock, par value $0.01 per share</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6ZTVlNzI4MzY3OGU5NDM3Mjg1MmIxODhhZTFmODhmYWQvdGFibGVyYW5nZTplNWU3MjgzNjc4ZTk0MzcyODUyYjE4OGFlMWY4OGZhZF8zLTEtMS0xLTYyMjEz_67042872-4742-41b4-9382-f52bece601a7">MGNX</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6ZTVlNzI4MzY3OGU5NDM3Mjg1MmIxODhhZTFmODhmYWQvdGFibGVyYW5nZTplNWU3MjgzNjc4ZTk0MzcyODUyYjE4OGFlMWY4OGZhZF8zLTItMS0xLTYyMjEz_554234c2-49cd-4752-b3e3-8990ccbd5a69">Nasdaq Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU1_6577c5fe-4722-4f30-a96b-acf6f0d74171">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU2_c8ca9adc-2d88-4e6c-8bab-e6218edba5d8">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU3_71027e71-f15f-4553-a6a7-4d29ddab38fe">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:2pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU4_10e0c5ea-7769-4f81-a4af-132fdb65ebc3">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU5_23e393d5-b377-4647-b60e-65211ced4176">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idac2edc8e1fb4278a30372d00eb431f8_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 8.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Events.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 13, 2023, MacroGenics, Inc. issued a press release announcing the preliminary results from one of its investigational pipeline molecules.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The full text of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference into this Item 8.01. </span></div><div><span><br/></span></div><div id="idac2edc8e1fb4278a30372d00eb431f8_13"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"></td><td style="width:16.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(d)     Exhibits.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1preliminaryresu.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1preliminaryresu.htm">Press Release, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1preliminaryresu.htm">February </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1preliminaryresu.htm">13</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1preliminaryresu.htm">, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data (embedded within the Inline XBRL document).</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div id="idac2edc8e1fb4278a30372d00eb431f8_16"></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SIGNATURE</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:48.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 13, 2023</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MACROGENICS, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and General Counsel</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1preliminaryresu.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0a3d3f5498de423bb88743130fcf6ba8_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 99.1</font></div></div><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:88px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:112%">MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Twelve of 42 patients (28.6%) in metastatic castration-resistant prostate cancer (mCRPC) cohort achieved &#8805; 50% prostate-specific antigen (PSA) reduction (PSA50), including 9 (21.4%) who achieved &#8805; 90% PSA reduction (PSA90) </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Nine of 35 patients (25.7%) with measurable mCRPC achieved confirmed partial responses  </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Manageable overall safety profile observed across multiple expansion cohorts </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Company plans to initiate Phase 2 study in mCRPC in 2023 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ROCKVILLE, MD, February 13, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ&#58; MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced preliminary safety and anti-tumor activity data from the dose expansion phase of the Company&#8217;s ongoing Phase 1 clinical trial of lorigerlimab, a bispecific, tetravalent PD-1 &#215; CTLA-4 DART&#174; molecule. This investigational molecule was designed to block PD-1 with enhanced CTLA-4 blockade on dual PD-1&#47;CTLA-4-expressing cells, such as tumor-infiltrating lymphocytes (TILs), while maintaining maximal PD-1 blockade on all PD-1-expressing cells. The preliminary data is being presented in a poster titled &#8220;Lorigerlimab, a Bispecific PD-1 &#215; CTLA-4 DART Molecule in Patients with Metastatic Castration-Resistant Prostate Cancer&#58; A Phase 1 Expansion Cohort&#8221; (Poster #155) at the American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium taking place February 16-18, 2023, in San Francisco, CA. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Cohort Expansion Results Update</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The ASCO-GU abstract included data as of September 10, 2022&#59; updated data as of a December 12, 2022 cut-off are included below and will be presented at ASCO-GU</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As of the December 12, 2022 data cut-off, 118 patients with mCRPC, melanoma, non-small cell lung cancer or microsatellite-stable colorectal cancer were enrolled in the cohort expansion phase of the lorigerlimab Phase 1 study at the dose of 6.0 mg&#47;kg, administered intravenously every three weeks (Q3W). Confirmed objective responses were observed across the histology-specific cohorts&#59; preliminary efficacy results for mCRPC are presented in the poster and below. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Preliminary Safety Results</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The safety analysis is based on 127 patients who received lorigerlimab at a dose of 6 mg&#47;kg Q3W, including 118 enrolled in the four dose expansion cohorts plus nine patients from dose escalation. Median exposure was 14.4 weeks (range&#58; 1.9 - 100.1 weeks) with a median of four infusions administered per patient. Twenty-four patients remained on lorigerlimab as of the December 12, 2022 data cut-off&#59; 103 discontinued for the following reasons&#58; progressive </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">disease (PD) (n&#61;66), adverse events (AE) (n&#61;31), patient&#47;physician decision (n&#61;5), or death due to PD (n&#61;1).  </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The results demonstrated a manageable overall safety profile. Treatment-related AEs (TRAEs) occurred in 86.6% of patients, with the most common among them (&#8805;15%) being fatigue, rash, pruritus, hypothyroidism, and pyrexia. Rates of grade &#8805;3 TRAEs and immune-related AEs were 34.6% and 7.9%, respectively. AEs resulted in treatment discontinuation in 24.4% of patients. There were no fatal AEs related to lorigerlimab. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Preliminary Anti-tumor Activity in mCRPC Cohort</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As of the December 12, 2022 data cut-off, 42 patients had been enrolled in the mCRPC expansion cohort. Patients had previously received a median of two prior therapies (range&#58; 1 &#8211; 9) for advanced disease, with 35 patients (83.3%) having received docetaxel and 34 patients (81.0%) having received androgen receptor antagonist therapy. The median exposure to lorigerlimab was 19.2 weeks (range&#58; 3.3 - 55.1 weeks), with a median of five infusions administered per patient. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A total of 35 patients with mCRPC had measurable soft tissue disease per RECIST v1.1 at study entry. Nine of the 35 patients (25.7%) achieved confirmed partial responses (cPR). The median duration of response for these nine patients was 4.6 months (range&#58; 2.8 &#8211; 8.6+ months), with four patients remaining on lorigerlimab as of data cut-off. Among the other five patients who had achieved cPR, four discontinued due to unrelated adverse events, and one patient discontinued due to physician decision. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Reductions in PSA levels of &#8805; 50% were observed in 12 of 42 patients (28.6%), and 9 of the 12 maintained PSA50 response &#8805; 3 months. Nine of 42 patients (21.4%), including the nine who achieved cPR, had reductions in their PSA levels of &#8805; 90% as of the data cut-off.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;To date, checkpoint inhibition has not fared well in the treatment of patients with late-stage mCRPC. Previously, anti-CTLA-4 therapy, whether alone or in combination with an anti-PD-1 agent, resulted in increased risk for immune-related toxicity with very modest anti-tumor activity,&#8221; said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. &#8220;We designed lorigerlimab to have preferential blockade on dual PD-1&#47;CTLA-4-expressing cells such as TILs, which are most abundant in the tumor microenvironment. As part of this study, biomarker analyses indicated that lorigerlimab was shown to induce T-cell activation as evidenced by an increased frequency of circulating Ki67+ and ICOS+ T cells. We believe we are seeing the benefit of lorigerlimab&#8217;s design and are very encouraged by this latest data set from our ongoing Phase 1 study. Looking forward, we plan to initiate a Phase 2 study of lorigerlimab in patients with mCRPC later this year and anticipate providing an update on the proposed study later this quarter.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ASCO-GU Poster Presentation</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">MacroGenics&#8217; lorigerlimab poster presentation will be available for on-demand viewing on the ASCO-GU website and on the &#8220;Events &#38; Presentations&#8221; page on MacroGenics&#8217; website at http&#58;&#47;&#47;ir.macrogenics.com&#47;events.cfm. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">About Lorigerlimab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Lorigerlimab (previously known as MGD019) is an investigational, bispecific IgG4-based, Fc-bearing DART molecule that was designed to enhance blockade on PD-1 and CTLA-4 dual-expressing, tumor-infiltrating lymphocytes, while maintaining maximal PD-1 blockade on all circulating PD-1-expressing cells. In addition to the study described above and presented in the poster, MacroGenics is also evaluating the activity of lorigerlimab in combination with vobramitamab duocarmazine (previously known as MGC018, an investigational B7-H3-directed antibody-drug conjugate) in a study in patients with advanced solid tumors. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">About MacroGenics, Inc.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">MacroGenics (the Company) is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Cautionary Note on Forward-Looking Statements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Any statements in this press release about future expectations, plans and prospects for MacroGenics (&#8220;Company&#8221;), including statements about the Company&#8217;s strategy, future operations, clinical development of the Company&#8217;s therapeutic candidates, including initiation and enrollment in clinical trials, expected timing of results from clinical trials, discussions with regulatory agencies, commercial prospects of or product revenues from MARGENZA and the Company&#8217;s product candidates, if approved, milestone or opt-in payments from the Company&#8217;s collaborators, the Company&#8217;s anticipated milestones and future expectations and plans and prospects for the Company and other statements containing the words &#8220;subject to&#8221;, &#34;believe&#34;, &#8220;anticipate&#8221;, &#8220;plan&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;estimate&#8221;, &#8220;potential,&#8221; &#8220;project&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, &#8220;could&#8221;, &#8220;can&#8221;, the negatives thereof, variations thereon and similar expressions, or by discussions of strategy constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including&#58; risks that MGC018, MARGENZA or any other product candidate&#8217;s revenue, expenses and costs may not be as expected, risks relating to MGC018, MARGENZA or any other product candidate&#8217;s market acceptance, competition, reimbursement and regulatory actions, the uncertainties inherent in the initiation and enrollment of future clinical trials, the availability of financing to fund the development of our product candidates, expectations of expanding ongoing clinical trials, availability and timing of data from ongoing clinical trials, expectations for the timing and steps required in the regulatory review process, expectations for regulatory approvals, expectations of future milestone payments, the impact of competitive products, our ability to enter into agreements with strategic partners and other matters that could affect the availability or commercial potential of the Company's product candidates, business, or economic or political disruptions due to catastrophes or other events, including natural disasters, terrorist attacks, civil unrest and actual or threatened armed conflict, or public health crises such as the novel coronavirus (referred to as COVID-19 pandemic), and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">this press release represent the Company's views only as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, except as may be required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.  </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">### </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">CONTACT&#58;  </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Jim Karrels, Senior Vice President, CFO  </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1-301-251-5172,  </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">info&#64;macrogenics.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">MacroGenics, Inc. </font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgnx-20230213.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e94095-42fb-4d36-a78d-ecdd0d27872f,g:2229d6f8-a959-48ea-859e-69cdf90cdf26-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mgnx="http://macrogenics.com/20230213" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://macrogenics.com/20230213">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20230213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20230213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://macrogenics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mgnx-20230213_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e94095-42fb-4d36-a78d-ecdd0d27872f,g:2229d6f8-a959-48ea-859e-69cdf90cdf26-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_75682723-88d4-43cd-8599-ce3fcd9e13af_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_acad5336-f4b4-4499-bd67-dbedf9d3da13_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ffc1bf88-0ddf-4ce5-ba5c-5932e80ec635_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2796d72b-b40a-48cf-8de8-b787d9bd1968_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_59b420ef-c03b-46e5-a223-3290628b6cdf_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_55f2d050-073f-4af8-81d9-b0032fb940cb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_73c4cde1-6ad1-49e9-b07f-adbc541aaeb2_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4ca76890-dcb9-4204-b879-63121e5f8d20_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fa9d29b8-f7ed-4b61-a10c-92f7fb01da30_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_683f621a-b9d1-4474-9493-ff7fc668d725_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_df5c0654-d057-4d9b-98e2-197f3270949b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_d9daf3cf-50b3-48d2-ab97-3aed1968239f_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_92aed76d-9854-420d-a557-d5015516bd29_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ff28bd50-c5af-40ec-9095-0017802782c4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_91a869a6-67b5-4465-a204-72b83b0083db_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5a781efd-6656-4de0-aa11-50a96ad3afc4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7f9f1f1a-9f8c-48e9-865f-b3fca012c42f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_254df70c-22c9-4bc4-b878-15db3918161a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b05bfc75-0f57-449c-9f21-5b1f65d6bb60_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_89b7c013-1d24-46ad-9673-66e2a9fc553c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c5eea67b-df71-4070-ac9c-599781a41f7e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d694fed3-214f-44e6-b257-9399211f9337_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mgnx-20230213_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:d8e94095-42fb-4d36-a78d-ecdd0d27872f,g:2229d6f8-a959-48ea-859e-69cdf90cdf26-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://macrogenics.com/role/Cover" xlink:type="simple" xlink:href="mgnx-20230213.xsd#Cover"/>
  <link:presentationLink xlink:role="http://macrogenics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ce420056-ad9d-4082-8536-11635a9cbf8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_DocumentType_ce420056-ad9d-4082-8536-11635a9cbf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_57e7e471-c5b2-4aa3-9a42-d4aefbd55dd5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_DocumentPeriodEndDate_57e7e471-c5b2-4aa3-9a42-d4aefbd55dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a4c9d7dd-ba6d-491b-bf10-27318460e4a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityRegistrantName_a4c9d7dd-ba6d-491b-bf10-27318460e4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b39c050f-4df9-4bce-87cc-72ed5b072eac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b39c050f-4df9-4bce-87cc-72ed5b072eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_75144636-c911-4ba5-a3e6-9d990bfa6771" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityFileNumber_75144636-c911-4ba5-a3e6-9d990bfa6771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bf2e9ec4-8be9-46e5-9892-3e8903db6626" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityTaxIdentificationNumber_bf2e9ec4-8be9-46e5-9892-3e8903db6626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3a104a36-a967-4481-85ea-be7b25797a50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityAddressAddressLine1_3a104a36-a967-4481-85ea-be7b25797a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_dd0e4288-10c1-4f82-ab4f-21a6425c5a0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityAddressCityOrTown_dd0e4288-10c1-4f82-ab4f-21a6425c5a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_87c99adb-9e97-43ce-8cfc-e776833be7e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityAddressStateOrProvince_87c99adb-9e97-43ce-8cfc-e776833be7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1be861b2-55a6-4bc5-b609-4924281803a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityAddressPostalZipCode_1be861b2-55a6-4bc5-b609-4924281803a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c12c2e2c-481c-4d30-8a01-644cc3bd27ca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_CityAreaCode_c12c2e2c-481c-4d30-8a01-644cc3bd27ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a99513e0-b31a-457f-8018-9b0685280038" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_LocalPhoneNumber_a99513e0-b31a-457f-8018-9b0685280038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6e3482f4-a067-4562-a492-d1d18ea9fa35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_Security12bTitle_6e3482f4-a067-4562-a492-d1d18ea9fa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7ba59446-973b-44c8-b763-d54d6ea2d189" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_TradingSymbol_7ba59446-973b-44c8-b763-d54d6ea2d189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_db82109c-5de1-406d-bf99-f37a4327abbc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_SecurityExchangeName_db82109c-5de1-406d-bf99-f37a4327abbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_a9559ade-88c0-47c6-90d6-74910728ed27" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_WrittenCommunications_a9559ade-88c0-47c6-90d6-74910728ed27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_995d155f-befa-4b04-8aad-f0068be5b62a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_SolicitingMaterial_995d155f-befa-4b04-8aad-f0068be5b62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4f97cc80-ae9c-4c2e-bdb9-fe937183110d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_PreCommencementTenderOffer_4f97cc80-ae9c-4c2e-bdb9-fe937183110d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_54f47d77-d0e4-499d-865d-db9a3948e245" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_54f47d77-d0e4-499d-865d-db9a3948e245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_54263127-0e8b-4652-b99b-d7844a357a47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityEmergingGrowthCompany_54263127-0e8b-4652-b99b-d7844a357a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c6f8a904-1886-4628-909f-161a489a3f2c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_EntityCentralIndexKey_c6f8a904-1886-4628-909f-161a489a3f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c9b0ccfb-d96b-4ffd-803c-166043009f49" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7ed37bac-4e1e-472b-8766-9cb4ffd11df8" xlink:to="loc_dei_AmendmentFlag_c9b0ccfb-d96b-4ffd-803c-166043009f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f6039d02-c613-44b8-aa38-7fc3ae72cdcf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" #* 7H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBD=P@R: &W$Z6T+3RLJJBY9F;  [G-?!'[8'[1VL_M#?
M$6W^&?PT:XFT6UO5M[&&TD(;5+HMCS.,97)P@/NW< >E?\% /VHGT.VG^!G@
M/5,75S'CQ%=PMS!&V,6X(Z,P(W>BD#^(XL_L _LNR>$["'XX>.=/5=2OX\Z'
M:S+S;6[CF8C'#N#QZ(<_Q8&EN74#W?X!>#_$7@#X0:%X.\6ZLU]J5A8JEW.T
MA;#$E@F3U" A >X4&NPH  Z"BLP"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***"<<T %>0?M>?M+:;\ _ >S2IXY/$>J*R:1:MSY?]ZX<
M?W5/ !^\Q QC<1W'Q<^*?AGX.^!;WQ[XIN]MK:1_NXD(WW$I^Y$@[LQ_+DG@
M&O@KPEH'Q(_;A^/LE]K-PT23-YNHW42DQ:;9J2!&GOU50>2V2?XL5&/4#I?V
M+?V;;_XY>-Y/BIX^$EUH=A?-)(UQEO[4O/O%22?F4$Y<\Y/RGJ37WI%$J(%\
MM5V] O:LSP7X,\.> _#%CX3\+Z9':V6GVZQ6\,8Z #J?5CR2>I))[UK42ES
M%%%%2 4444 %%%% !1110!7DOX(KM;.5]K/_ *O=T;V'O5@'/2H;ZQMK^W:W
MN8MRM^A]1Z&LF+5[K0+Q=,UN7=%(<6]V?XO9O0^] &Y10"#T-% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  "#T-
M%?)WPO\ ^"C=[J/Q4F\*?%;PI9Z+I$UTUO;W4?F"6Q?=M N-S$$9&&("[3VP
M#7U=;SQW$"3Q2*RNH965@001U'M3<7'<!]%%%( HHHH *@U+4;#2K"?4M3O8
M;>WMX6DGFGD"I&@&2S$D  #N>*F9L+D5\:?M_P#[4BZO>3? KP)J!^SPL!XC
MO(6_UKCI;*1V'!?!Y.U>S9J,>8#S_P#:2^-?BO\ :S^+=IX+\ 6UQ<:3#>?9
M] L$7!N'/#7#YX&>V[[JCGC=G[(_9N^ 6A? #X?1>%K(K/J%QMFU?4%7;]HG
MQSCT1?NJ.P]R:\Y_85_983X7^&%^)?CC32OB/5(<6\,R$-I]LW\&#R'?JV>0
M,+Q\P/T51*71  &!BBBBI **** "BBB@ HHHH **** "JNK:7;:Q:-97:95E
MZ]U/8BK5% ')Z'K]YX<U/_A&=>/[O.+:X?ICMGV_E75JP89!K'\9>&H]?TQE
MA3_2(\F%O7U7Z'^=97P[\6O>L?#VJ2?Z3""(RW5E'8^X_E]* .NHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y@_;>
M_8['C>UN/BY\,M/SKD,>[5=-A7_D((!]]!WE S\HY<< %OO<=^Q!^V"WAN>U
M^#'Q4U(_8BPAT+5+F3'V9B<"WD)_@)P%8_=)VGY=NW[0(S7R'^W)^Q[YK7GQ
MJ^%NE9;+3^(=+@C)W=VN8P <GDEU[_> )R#<9=&!]=1OO3=BG5\F_L.?MB'6
MEM/@O\4M6_TQ56+0=4N)L^>O06\A)/SC^%OXAQR0"WU@CB0;@*EH!U%%<1\>
M?C7X9^!WP]NO&GB!]TB_N]/LU?:]W<'[L8]L\D_PJ"?2EN!P'[;'[3J?!'PG
M_P (IX5O!_PDVL0LMLR8+6,)R#.?1NH3W!."%(KQ;]@[]F&7Q_KR?&WXA6;2
M:79W);2;>Z!)OKG()F;/WD0\CKN;V4YXSX+_  R\<_MH?'&Z\1^+[^9K+[2+
MGQ!J*9 CCS\EO'_=+ ;5 SM4$G..?T%\.^'])\+:+:^'="L(K6SLX5BM;>%-
MJQHHP *T^&.@%N-/+& :=1168!1110 4444 %%%% !1110 4444 %%%% !7G
M'Q0T>X\/ZY#XMTD^7YDF9&7^&0=_H1U]?QKT>L_Q1HL/B#0KC291_KH\*W]U
MNH/YT 1^$O$=MXFT.'5+?:-RXD0-]QQU'^>QK4KR+X2>)Y_#WBV3PUJ;>7'=
M,8RK?P3*<#\^1^5>NJVX9%-@%%%%( HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *:\:NNTJ*=2;ESC- 'Q-^VY^Q])X'O;CXR?"R
MS9=+DD\W5M-MU(^PR$Y,T>.D9.,@?<//0_+Z/^Q1^V GQ,LH?A9\2-1V^(K=
M,6-],V/[2C'8GIYP YZ;QEAR&Q]&W=M:7EO):W42R1RJ5DCD&Y64C!!!X(([
M=*^$_P!L#]E/5?@7XA7XK_"Z.>+P_)<K)BU=O,TB?.0 1SY9/*MGY2 I_A-5
M&TM /N+Q%XET7PKHMUXC\0:C':6-E TUU<3-A4C49)_(5^?/Q9^(7CW]M+XY
MVNB>%[.1;5IC;Z%I[,=MO#U>>7'0X&]SS@ *,X&8_C'^UY\3?CIX!T7X9ZG#
MY/DLHU:2S+!M5F#8C+*.@'#;>09,-QA0/JC]BS]F.+X'>#F\1^*K1?\ A)M8
MA5KS/_+G">5MU]\_,Q_O''(44TN178'H'P,^#7AKX'?#^S\$^&X@WEKYE]=L
MH#W4Y #R-^0 '\*@#M794T%%& :4,#4 +1110 4444 %%%% !1110 4444 %
M%%% !1110 4C#(Q2T4 >'_'+2[GPUXX&K609%O%6>%E[2@@$#WS@_P# J]<\
M%^((O%/ABSUZ(_\ 'Q"&8 ]&Z,/P;-<3^TQI?VGP?#K**WF6-V!NSQM<8/ZA
M:J_LO>)?M_A[4/#S-S8W2RQ\_P ,@/'X%#^=/4#U2BDWJ.<TWSX_7]*0#Z*:
M)8VY#4+*C=#0 ZB@$'I10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%%  <XXKX]_:#_;"^-7A+XM:QX1\':M:Z?8Z;=>3'BQCD:3@99C(K<Y/08P
M ,\U]A5^=O[3WS?'WQ0I_P"@I(/T%?AOCOGN<9%PYAZF7UY4I2JV;BVFTHMV
MNM=TMC](\,<KR_-,XJPQ=)5$H-I25U>Z5[,[#P7^WO\ &G1=:CN/%]W9ZOI^
M\&ZA:Q2.0)GDHT849QZ@\U]F6RZ!X\\*_P"DPPZAINJ68W1RJ&CFB=>A'<$'
M]:_/'XD> )?"6D^&?$R6S_8_$&A0W*R,!M,R_)(@]^%8_P#73CV^LOV$OB4W
MBWX.IX8O+G?>>'[@VK!NOD'YHC] ,K_P#\:^9\'>,>(9<15\ASS$2J2E%3IN
M;YGLFTF]=8M27D>SX@</Y1_9-+-<KI*$5)QFHJRW:U6R:DFM!OPR_83^$'PQ
M^)"_$>RN+^\:WD>32]/O61HK21NC#"@L5&0N>G7D@$9_[7/[5GB/X0:I9^!_
M "VO]I3VOVB[NKB/S!;QDE44+D#<2I.3D #IR*]WU348--LY+^YE58X8VDD=
MSPJ@9)/T'-?G1\1_%.K?&KXOWFM6BM)<:YJRP:?%MQ\I810K[84)^.:^S\:.
M,,=P[D5+"Y=4<<3B)J,7%V:BOB:>Z;;C%6[GSWAYP_A<XS2=?&14J-&/-)/9
MM[)^5DW\CKE_;@_:15Q(WC.W<;L[&TFWP>>G" _J/KWK[)^"_C;4/B-\,-%\
M;ZG:QQ3ZE8K+-'%G:'Z'&>V0<>U? _QJ\)6?@+XHZIX-L>8M-:*!6_O$1)EO
MQ.3^-?</[*AQ^SMX4/\ U"Q_Z$U?$>"N?\48WBS'Y=FN*G6]E%JTY.5I1J1B
MVKWM?7Y'TGB-E>1X?(L+C<#0C3YVG>*2;C*/,KV^7XGH9=1P6I%EC;[KUG^(
M]=L?#>BW?B#4I5CMK*WDGN)&Z*BJ23^ %? /B/\ :>^.'B'7;O5[;XBZM80S
M3,\-G9WC1QP(3\J*%P, $#.,DC/>OUCCSQ(R?@&-!8JG.I*K>T86O96NW=JR
MUT^9\-PQPCF'%+JNA*,(T[7<KVN]DK)W/T.\V/.W>,TZOCW]C;]I+QYJ/Q2C
M\$>/O%E]J=KJD#K9M>2;VCG4;Q\W7#*&'7KM[YKZ_BD#)DFO6X+XRRWC?)_[
M0P<7%*3BXRM=-6WMIJFFCBXBX?QG#>8/"8AINR::V:?KYCBZK]YJ3SHB=OF#
M/I7G_P"T%\?_  U\"?"W]L:@BW=]<Y33M/1\-,XZDG^%5R"3[@ $D"OCGQM^
MUA\>/'U\96\:76EPEOW-GHLA@5,G@;E.YC]6/X5\_P :^*W#G!6(6$K*56N[
M/DAND]N9O1-]%OY6/4X<X'SCB2BZ]*T*2TYI=?1;OUV\^A^@QFB7K(*/,3&=
MU?GC+\1/VF_!4<>LZCXI\8V<3,"DFI37!B<_27*M^.:^J_V0?C5XJ^,_P^NK
M[Q>L+7VFWQMI+B&,+YR[%8,5' ;YN<#''05R\&^+.5\7YI_9OU:I0K.+E%35
MTU&S>JVLGU5O,VXBX%QV08'ZXJT*M--)N+U3?EK<]C#H>C4NY?6O@GXL?M'_
M !PM/B=K]AI_Q'U*UM[36+FWM[>UD$:1QQRLB@ #T ^IYJK;?%K]K:[L%U:W
M\2>,)+5H_,6Y2WE,;)_>#!<$>]?/UO'W(*6,JX>&"KS=.3BW%1>SM??:YZU/
MPNS:>'A6EB*45))J[DMU>WPGW^98QU>EW+CK7P5X,_;4^._A34(YM2U^/6+=
M& FM=1MURX!P1O0!L]>23CN*^R/A#\4]$^+W@2S\:Z"K1QW"E9K>1@6AD!PT
M9QW!_,$5]GP7XG<.<<5)T,'S0K05W":2E;JTTVFOF?-\1<'9QPU&-3$I2IRV
ME%W5^SO9_A8ZQI8T&6?%'FQ_WJ\9_:>_:LTSX((OAS0+6'4->N(MZPR']W:H
M>CR8.23V48)[D#&?EG4_C[^T1\2M=^SV/C;7)+J;F*RT-WAX'8)!@G'J<GU-
M>9Q=XP<-\*Y@\OC"=>NMXP6D7V;?6W1)M=;'?D/ .<9YA/K;<:5)[2F]_-+M
MYO0_0SS(_P"_0)(ST>OSLU/Q]^TIX$GCFU[Q7XRTXL<Q'4+JY16Q[2'!_*O8
M/V>_VYM?EUVW\*?&.:&X@NI!'#K21"-XG)P/-"X4KG^( 8Z\CFO)R/QSX=S+
M,8X+'4*F%G)V3G\.NUVM5?S5O-';F?AIG&#PDL3AJD*\8ZOE>ORZ/TO?LF?1
MOQAL8=1^&>N1N-WEZ?)+C_<&\?JM>)_ 36(?A['K/Q?\8ZO!I?AG3]/>*^U"
M\EVH6#J1CUZ8^K #)/'T)J=G%K>C7&G.RF.[MWC9BN5VLI'X]:_,O_@J'\=&
MU'QU9_LQ^"KTP^&_!T,?VZ&-L_:K]ER6<C@[$;'0?.\F:_2.+.)J/"^22QDE
MS2;2BN\G^BW?DCYOA7A^MQ-FT<)%VC\4GVBOU>R\V=M\?_\ @LEXGNM2N?#W
M[/'@VUM[-2T:Z]KD)DEE[;XX58*@[C>7SW4=*\/E_P""F?[;%R_F+\;FC'7$
M.AV '_H@UUG_  3N_8+M?VE;FX^)/Q06XB\)Z9="".TMY"CZE<  L@<<K$N1
MEA@L2 ,8)'Z1>!/@;\'OAOIW]F> _AKHFDQ-&%E%GIL2-)C^^VW<Y]V)-?EF
M4Y1QYQE0_M#$8Z5"G/X4KK3NHQ:LNS=V^Y^F9MFG G"&(> P^!C7J0TDY6>O
M9RDG=]TK)=C\R?"/_!5?]LCPYJ:WNK^-M/UZ"-</9ZIH<"H0>Y:W6)O7^+'%
M?=G[$'[:&F?M?^$M0O6\.?V3K&AO"FK6,<IDC(E#&.5&(!VL4<;2,J5YSD&N
MF^*'[&O[-'Q;L[B'QC\(='-Q<+AM0L;46MUGM^^AVN?H20>X-8/[)/[%?@W]
MD2_\3W'@WQ/J6I0^(YK8K'J"KNMHH1)L3<N-YS*WS8'&T8R"3]9P_D/&V1YQ
M!8G%^WPK3YKM\RTT^*[W[-^:1\MG^=<%YUE,I8?">PQ*M;E2Y7KKK&RV[I/L
MV>W1N@[T\.IX#5\,?\%9/VDOC9\(/&7A7PG\+_B!?:#:7FESW5Y_9[A))I/,
MV#<V,X ' &.3SGC'S#X;_:L_;T\8I-+X0^*7CK55MRJW#:;')/Y1.<!MB';G
M!QGKBKSCQ,RS)LVGETJ%2<X65XI-/1/36^S["R?PXS3.,IIX^%:G"$]?>;36
MK6NEMUW/V%+JHRS"D\Q/[U?D7+\=/^"DDZ>4WB3XF-DCC^S+GGG_ *YU^H7P
M@U'Q1>? KPWK'C(3?VU)X5M)M4^U1[)/M)MD,F]>,-OSD>M>OPWQGAN)*E6%
M.A.GR)-\Z2O=]-3R.(^$<5PW3I2J5H5.=M+D;=K+KH=D)HCTD% GA)P)!7XT
MZM^WO^U_JNIW&I2_'C7+<S2LWDVLJQQH"<[551@*.@'I7TI_P3,_;M^(OBSX
MFM\%/C=XUDU:/5XR^@:A?LOFQW"C+0%L#<&7<1DG#+@?>P/$RGQ4R/-,RA@_
M9SASNRE*UK]-F]]EYGLYKX99[E>6SQCG":@KM1O>W7=+;J?H'O3^]2>;&1D/
M7'?'W7]7\+? OQAXG\/WC6U]I_AF^N;.XC S'(EN[*PSZ$ U^<W[!W[5'[1G
MB_\ :P\)>%?%7QBU[4M-U2^F2^L+^^::*1?L\S8VOG'(!XP>*^BSSB[!Y#FF
M&P-6G*4J[LFK66J6OS9\_DO"^,SS+,3C:,XJ-!7:=[O1O3[C]2C+$IP7%'G0
M@9,J_G7B_P"WYXY\6_#;]D[Q9XV\"ZY-IFJ6D5J+6^ML"2+?=PQMC@X)5F&>
MHSQ@U\(_L5?M7?M(^)/VI/!WAKQ'\:?$&HZ?J6J>1?65_?--'+&4;(VOD#U!
M&"".*PSOC7 Y%G%#+JU.4I5;6:M97ERZZW_ Z,EX/QV=Y/7S&E4C&-*]T[W=
MHJ6A^J^]<9W4GFQYQOJO>7<%C:/=74\<<<:EI))6VJH ZD]J_.W]K/\ X*P^
M.-6\1W?@G]FBYBTS2;=FA?Q));K)<7C9P3$K@K''Z,06/!^7H?0XBXHROAC#
M*KC):OX8K64O1=O/H>?P_P -YIQ+B72P<=%JY/2,5YOOV74_1KS8SP'%'GPD
M9\P<\#WK\9=#^,_[;OQ*EFU3PI\1_B9K7V=OW\FD:E?RI"?0B(E5^G%>L_L9
M?MW_ +2GA_X[^'?A3\1/%UYKVEZUKD.F7UKX@4R7-L\KB,,)6_>!E8KE7)!
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MR^KFG#N&S65-QJ02YTU9I2M>_I+\&>*_MH>,[WQ;\>-4L)9=UKHRQV5I&O\
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M=Y5WX4)CY0"H[\YKK?\ @E?\;M,^)/[-%CX)N+\-J_A&1K"\MVP'%N79K>3
M_AV?)GUC->J_$O\ 9-_9W^,OB7_A+_B=\+-/U74OLZP?;)BZL44G:#M89QDX
MSS7Z13IYEG'!^%_L.NJ4^6'O6NK15I+9V=_(_/Y5,ORGB[%?VU0=6/-/W;V=
MV[QENKJVN_4^*?\ A]-\6S\P^#OAT?\ ;Y/_ (U]+?L$_ML:E^UWI/B)-?\
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M,5IZ,\GB#-."Y9;+#91A7&<FFYRZ)=%>4GKY-(_.GXQG_B[/BCG_ )F*^_\
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M6M:]E8^RQ/BEE>-R"IAJM&?MITW%M)<O,TU>][VN[[&+_P %,_\ DR;QL?\
MIG8_^EUO7YS_ +!0'_#8/@ 8_P"8\O\ Z U?KE\4/AIX-^+W@N^^'?Q!T=;_
M $?4HU6\M3,\?F!7#K\R$,"&4$$'J*\O^&O_  3U_96^$_C:Q^(7@?X>36^K
M:9,9;&>;6;J41.01N"O(5)P3U! ^M?5\4\&YGG7%&$S*A**A2Y;IMI^[/FTT
MMKMN?+\+\89=DO#.+RVM"3G5Y[-)67-!15];[KL=I^TE\%-(_:%^"VN_";5I
ME@_M2V(L[MD+?9KA?GBEP""=KJ"1D9&1WK\<?'_P_P#B)\"?B)-X0\7:;=Z/
MKFD70>-E8JRE6RDT;CJI(#*X]J_<I$#?*XKD?B_\ OA!\=-%71?BIX T_6(X
MU86\EQ'MF@R1GRY5(DC)P,E6&:Z^..!8\51A7H5/9UZ:LF[VDM[.VJL]5):G
M)P5QM+AASH5H.=&;NTK73VNKZ.ZT:>A\'?"G_@LQ\1?"WAB'0OBA\++3Q%>0
MQJG]J6FJ&SDF &-TB>6ZESW*[1GHOI/X5_X*A?M _'G]HWP/X)\+:59^&]"U
M#Q5:6U]I]I']IGNH'D57629UZ!-[?NT0\=>*]\OO^"2G[(%U.US!X?URW!.5
MMX==DV?3YMS8_&O1_@K^QG^SE^S_ '?]L?#?X:VEOJ."!JEY*]Q<J",$+)*Q
M* CJ%P#WKP\!P[XF3K4J.+QT51BTW;XI*+VNHJ3OV<CV,;GWAO3IU*N$P,G5
MDFES:1BVM[.3CIY1/FO]L#_@H+\=OV8_VL[SPEI-C9:EX9ATNS=='OK4Q[]Z
M[GD291N#;MRY.Y,+]TD&GI_P6I^'_P#8_F3? [6?MP4$0_VK"T6[W?:#^.RO
MJ[XR_LX_!/X^:8NG_%;X=:?JQC4K!<R1E+B$$Y(CF0B1,GDA6 />O%Y?^"1W
M[(TMTMS'I&O1J&R;>/6W,?T^8%OUKT,QRGQ%P^8UJF6XN$J4Y-J,[7AY*\9-
M+T=O(X<NS3P]Q& HT\QPLXU812<H-VG:VKM**N_-7\S\W_B;XW\6_M%_&?4O
M',?AHMJWB;5 UOI>FPLY+G"QQ(,$N<!5SCD\XZ@?7OAC_@CH;WPUI]YXE\82
MVFI36,+ZA:PKO2&<H"Z*W\0#9 /?%?6OP1_8]_9Y_9\N3??##X9V=G?;2#JM
MQ(]Q=;3P5$LI9D![JI"GTKTTP1YXB_2O/R/PKPT?:5\ZDJM6;OILNK[;M]CT
M,\\3L5+V=#)8NC2@K:[NUDN]DDN[):^+?VWOB!XTT/\ : C@T7Q3?6L>F6-O
M+9PV]TZ+&YRQ; (&2<9]1P>*^TJ^$_V[_P#DX:]_[!=K_P"@FN;QWQ&(PW!<
M)49N+=:FKIM/[3Z>AYOAC0HXCB*4:D5)>SENK]EU/N/1I'ETFVFD.6>!68^I
M(S5@H"<D55T$_P#$DL_^O9/_ $$5;K]CPS<L/!OLOR/SV>DV-$:KT%.VCTHH
MK8D;L7.<4NQ>XI:* &F)"-N*=110 FT&D\I/2G44 -5%48%'EKW%.HH :(DS
MG%*44KM(I:* &^6OI1L .:=10 WRU[BCRU'.*=10 FT>E)Y:?W:=10 TQ(>W
MY42$HFY5SCMZTZO(?VT/C0OP@^#-\;"[,>K:T#8Z7L?:Z,P_>2@CD%$R0?[Q
M09&:$M0/BO\ :O\ BD/BW\==;\4VERTUC;W'V+3/[ODQ?*"/9FW/Z_/7UY_P
M3V^'?_"'_ &#Q!>V@2Z\0WKWQ;^+R<!(@?;"EQ_UTKX>^%/P_P!5^*GQ$TCX
M>Z/D2ZG>)$TBKN\F/J\A]E4%O7BOU+\/Z-IWAS1+70-'M%M[2RMT@MH5'"1H
MH50/H!6DOAL!;*J>HH"J. *6BLP&F-32JH48%+10 %0>2*;L7.<4ZB@ V@]J
M-H':BB@!-HZXI:** &^6N<XI=B^E+10 TQJ3DBEV*.@I:*   #D"@C/!HHH
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M[=__ "<->_\ 8+M?_037XAX_?\D32_Z_T_RD?I7A7_R4DO\ KW+\XGW#H/\
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M=0/:O:OV?_A-\*]6$,VJ?#/P_<OM'S7&BP.?U2OH33M&TC184M='TJVM(U7
MCM8%C4?@H%3S170#\^M%_92_:T^->K_V]XC\/ZHLDC!9-4\67K1L!CN)"96
M&.BD#VZ5[/\ #+_@F5X=LY([_P"+?C.;4&5LMI^CJ88C[&5AO8?0(?>OJR+H
MP_VOZ4ZAR8'.?#[X2?#KX6:5_8_@#PG::7"RJ)3;Q_O)<="[G+.W^TQ)KHU
M48%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
3%%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139679894574704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 13,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MACROGENICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1591613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9704 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-5172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGNX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001125345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>mgnx-20230213_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgnx-20230213.xsd" xlink:type="simple"/>
    <context id="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125345</identifier>
        </entity>
        <period>
            <startDate>2023-02-13</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF80L2ZyYWc6YTk0ZmQ4ZTQ2MWM5NDNjOWEzOWFkMzlhNGFkNWNjYTEvdGFibGU6ZDQxMDdiNzljNGE2NDExNGEyMjUzMDJlOGIzYjY0MmEvdGFibGVyYW5nZTpkNDEwN2I3OWM0YTY0MTE0YTIyNTMwMmU4YjNiNjQyYV8yLTEtMS0xLTYyMjEz_086c52a3-363b-47b1-9669-79cabbce70fc">0001125345</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF80L2ZyYWc6YTk0ZmQ4ZTQ2MWM5NDNjOWEzOWFkMzlhNGFkNWNjYTEvdGFibGU6ZDQxMDdiNzljNGE2NDExNGEyMjUzMDJlOGIzYjY0MmEvdGFibGVyYW5nZTpkNDEwN2I3OWM0YTY0MTE0YTIyNTMwMmU4YjNiNjQyYV8zLTEtMS0xLTYyMjEz_acfee689-251f-4f1f-8ebe-0ba01ef6e6ba">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xMDY_60caa835-3657-458a-b6e6-043c09ee01c9">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjYw_fd9536ac-c271-499e-bce5-85b470c23046">2023-02-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8yNzA_84cdc960-16e5-4fdb-833f-4301b9920340">MACROGENICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6M2IwZDVlNTNkZTMzNDA0NDgzMTQyOWExN2EzZTUzYTgvdGFibGVyYW5nZTozYjBkNWU1M2RlMzM0MDQ0ODMxNDI5YTE3YTNlNTNhOF8wLTAtMS0xLTYyMjEz_38d06fe4-b122-403d-93c4-64277812102c">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6M2IwZDVlNTNkZTMzNDA0NDgzMTQyOWExN2EzZTUzYTgvdGFibGVyYW5nZTozYjBkNWU1M2RlMzM0MDQ0ODMxNDI5YTE3YTNlNTNhOF8wLTEtMS0xLTYyMjEz_4fbe6afa-c2d7-4cef-92e1-355ccce043bf">001-36112</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6M2IwZDVlNTNkZTMzNDA0NDgzMTQyOWExN2EzZTUzYTgvdGFibGVyYW5nZTozYjBkNWU1M2RlMzM0MDQ0ODMxNDI5YTE3YTNlNTNhOF8wLTItMS0xLTYyMjEz_4fcea4b9-ea03-4ea2-b2cb-9397d0bb7fd8">06-1591613</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8wLTAtMS0yLTYyMjEz_946177e7-dbc8-4eb4-a5cd-e5667e9b9974">9704 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8xLTAtMS0xLTYyMjEz_db96e6e4-3359-4e5d-b98f-7d4227406a7e">Rockville,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8xLTEtMS0xLTYyMjEz_9538eb9f-9d22-45fc-9bb7-420acfaf8d6a">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6MTE3NDhlYmRiOWU1NGJkOWE4OGFiNTA5NzAyZDA2OWYvdGFibGVyYW5nZToxMTc0OGViZGI5ZTU0YmQ5YTg4YWI1MDk3MDJkMDY5Zl8xLTMtMS0xLTYyMjEz_03889c68-9779-4b93-b571-980319e11e41">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8zODY_76d73a1e-8530-483c-990f-3b93dc954f01">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8zOTA_0177da95-169a-4b44-beb6-55776ad9facc">251-5172</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6ZTVlNzI4MzY3OGU5NDM3Mjg1MmIxODhhZTFmODhmYWQvdGFibGVyYW5nZTplNWU3MjgzNjc4ZTk0MzcyODUyYjE4OGFlMWY4OGZhZF8zLTAtMS0xLTYyMjEz_37521054-3c37-4a57-9209-698f761d28e3">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6ZTVlNzI4MzY3OGU5NDM3Mjg1MmIxODhhZTFmODhmYWQvdGFibGVyYW5nZTplNWU3MjgzNjc4ZTk0MzcyODUyYjE4OGFlMWY4OGZhZF8zLTEtMS0xLTYyMjEz_67042872-4742-41b4-9382-f52bece601a7">MGNX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGFibGU6ZTVlNzI4MzY3OGU5NDM3Mjg1MmIxODhhZTFmODhmYWQvdGFibGVyYW5nZTplNWU3MjgzNjc4ZTk0MzcyODUyYjE4OGFlMWY4OGZhZF8zLTItMS0xLTYyMjEz_554234c2-49cd-4752-b3e3-8990ccbd5a69">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU1_6577c5fe-4722-4f30-a96b-acf6f0d74171">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU2_c8ca9adc-2d88-4e6c-8bab-e6218edba5d8">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU3_71027e71-f15f-4553-a6a7-4d29ddab38fe">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU4_10e0c5ea-7769-4f81-a4af-132fdb65ebc3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYzJlZGM4ZTFmYjQyNzhhMzAzNzJkMDBlYjQzMWY4L3NlYzpkYWMyZWRjOGUxZmI0Mjc4YTMwMzcyZDAwZWI0MzFmOF8xL2ZyYWc6NTQzNzE1NDVhOTQ4NDg3Nzk3NzA3ZGE1YjBlMmQ4YjUvdGV4dHJlZ2lvbjo1NDM3MTU0NWE5NDg0ODc3OTc3MDdkYTViMGUyZDhiNV8xNjU5_23e393d5-b377-4647-b60e-65211ced4176">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M']'LID"!STY@Q/;D$Z^&PJ4\V*-1O]ULM3&RTOA]W+,'D,HP3^=CQ-:5/+C
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "/D4U6EXJ[',
M   3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!
M5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]I
MSI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z
M3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=
MQ_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( (^1
M35:JQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P
M%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\
M>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6V
MG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*
M0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/
MJ!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#
MK+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPY
MZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " "/D4U6)!Z;HJT
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M2P$"% ,4    " "/D4U6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (^135:AG%!,[0   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M (^135:97)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ CY%-5EI1U.Q&!   @!   !@
M     ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M (^135:?H!OPL0(  .(,   -              "  8@,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ CY%-5I>*NQS     $P(   L              ( !
M9 \  %]R96QS+RYR96QS4$L! A0#%     @ CY%-5JK$(A8S 0  (@(   \
M             ( !31   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (^1
M358D'INBK0   /@!   :              "  :T1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (^1359ED'F2&0$  ,\#   3
M          "  9(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  -P3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mgnx-20230213.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://macrogenics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mgnx-20230213.htm">mgnx-20230213.htm</File>
    <File>exhibit99-1preliminaryresu.htm</File>
    <File>mgnx-20230213.xsd</File>
    <File>mgnx-20230213_lab.xml</File>
    <File>mgnx-20230213_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mgnx-20230213.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "mgnx-20230213.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mgnx-20230213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgnx-20230213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mgnx-20230213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mgnx",
   "nsuri": "http://macrogenics.com/20230213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20230213.htm",
      "contextRef": "i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://macrogenics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20230213.htm",
      "contextRef": "i7b8763f0cf46463fac2131583cd0397d_D20230213-20230213",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001125345-23-000021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001125345-23-000021-xbrl.zip
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M'1P=[1.I)I.[A-/ I!)Q9P)-5@RCJGC_AX1@9+9:8]Y[Q,:[KW_<W\+!<_G
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M[QK@3--4 (U'D-*YXP&-RE;'G_=]%&ZKKXG@U5^KND^RJKLE&['*%R37S(4
MBKXDB?C;.H2@A.,H[3)*S>T\#H 99MQDS<MSQ&1C#4#/7!LHD$6VGI^[5Y/O
MLD'VQ/=F2:6#LG3;I*P42[$2YJ!E)](=_ODM8@#Y3$R55UW',@>F+;XMRA(V
MTQ!B6)'47#H!E,&?78&4WAP:S$@ 30&7%$9R350= R;4"EVRTGY;-D<N2WY
M)ROI;^2DKJ5=;5;)QM>5YK_0E:S<5C5VP=>E6SOXN)LV+#G@N/!'_TA-ZZG/
M9=Z[N[M/N3HP_O#^_G)\[SCFES[\_=\Z%C](A!<B%G<JH;.>/^E U6=..F+\
MZL,7EW/0'?4'W>'1H'LT.!EV:GFV"7%T/ H&_P8AJ*[X?/?X\&*M5OA%ZE]?
M>D?^R7+FTV("!^[OA?%?+GOY_U!+ P04    " "/D4U69;6983X4   QB
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MVY3F8A!$N,^%3U37]&'V_C)@6;\N2]+_5_)Z6Q_2(0&.\I(:M"Z^%YW<Z4H
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M6#/ B',O&9%D LI@,X]OKI$U68U77URDC)4D_\FC9P>\%Z0B(IFY4/)K<3S
MOGUJ:911VY"P; ";:S[SL*6J/M942?9L6Y%43:IL.=L[!^V]IMO:.=Q$+7>G
MNHX,G_=8#S(8C:X@ FBC.29@!07AA9J^9@5$4G0XY%1$*A@*(K33)Z"QDW?K
M,,M[B'5&O)#/0/#BA/$$ R0A&::\/OOR?A;%+D+T.&_T?D"27A!A+\ZR>% 7
MT8H+GF0!)6$YS7S&17$9R+#MJF[(0FBS!/ZQV<!EF*.:RW,M8W?+5+5J:=;2
M8JDJ+RW[5K>*794DY=&[%=#JRXMO=EO+,5%@ _ MJ/*Q EJH;# DC 51KZX,
MQT@&%-_@HI#[=U$>#ROKYI])SZ*E6Q&-$_":\AVCPPP\EIUX%&7)9"=F\^Z,
MV((3L<&,#Y/X0O3S2OV8(CKN**W+D\;7T.VXYR<=9^HVMB5H-W4Z7R;MX^;8
M59K3D\[1M-OIW8J.QU/H[]P]/I(=Y2!TIH[D-+Z -7#&;J.E=SM-M=MQ1;]]
M@/%RO[,]'QU7+289/M>P)RL*UB2585NE&C8TQ30M69$EA8+'RT-R21+^;6LP
M$Y,W"7BX!.P&(8?>/9CA&S=_GYMO[?5HOL<-XA/PZIF)-<I];"M<QJJN4TJY
MI*F>+_8KX!=#EI4W=GYJ=NZ0<:O<"Z*Y4G_C[95YNW6;MRDGFF=C3B05:YPH
MV%.H!^H:B"%YGNDS"WC;P+)NRX;\G:7J$[@MA9/X8HR^^JH@9_V-W+T0(;YV
MUN<)^C1*@I0%>>QO'=S_>TX'UC5SSM.[I])EKXS*._%@$*3IZR1JL<H3+@$J
M].8;50NJM@X.47,P#.,)3UXM7><-(W+CZB+RYCJZEB_65]U>>>Z @&56-<5X
M2$! 4:N:M7QU_N" @%XU=/W1NY6EJFD^09P!H+57ZW:AP38>4^C++K"H7U>T
MJBDX8/9CGN=[]>LOX\1N,Y;P-"T_]@$ ^34[L.!HNHU^V!T<!&UP1MV]3^?@
MN&IM*'<[VSJT%>,I[>/N;0=V['2HU-[[&ISLM71P<J7NX LXKCVM>]R2G<:Y
MZC3$W+KZ27@5:IA<.;"V9LBFR4W,/&J! ^MIF.B48:X;ALEMS[9-K;)EFY*&
M',X$GZ*=G*]0(PDN?CSV( F9J-R_ZL.]Y%Q>EDK=SRPK._"UG73BRU<=E'L>
M21G?"<HQSS:XP36LJN(T!-<9]FS+QR;3%,74)(.8O+)U$-/SBR ,^>92T7A\
M__!G9MI\1=A./B?Q19 ?N?B)X\W/QMJW(G2VKEK<LWUL,Q%OUGV*;<\SL:9(
MA/K$MYA!*EL.228AB=@/,/8]M/T"&2@<FL5QO)]9!#['P./A23 L-ES>^/N[
M_.W<.F*B6I9-#0O;I@FJV[-5[.FFC&U+4F6;RS+7Y,J6(EFZ]$WF?KBG_W*L
MNV2Q7K*6V'K_G(!B#8;@V37'G(XR<.M0VX<E,$_?_0*RO01!(&Y(R-N[NQQP
MOX7_NF4I7&=:_)ZBC(=\V(\CCJ(\EK6)@!?"D: 2(@DG0$7&KU+ERJF]1!;B
MQA,J6^$7;\-D7ZUZ?7 2TK3=Z)Z:!C-5(G-LZ:J$-< :MFW)QRKH249M7?,E
MT(ZJ)-_6C>^>,GER/P8U\%FPYBO>G?H!PG2V3R58F3-BZU@V; )F2].PQST#
MZ[II&H39@%(*9DN7L2Z;W]DW74-%].)9D*MI'C?.$!D.0S!+H/77!^A[)MQM
M[,*ZB2=EPEV"RL?2#P"][XM$NZC'&3H4"RVT3](,'>3ITO=/O5L:!+^)#(_0
M\UX2CR*&2[SX^=_[9^! 69]/S4]RJ\@3F/YPT;D#9<.;G3@0V?OU%\OR,R7S
M05E^6E6R5\N;NU=07ZOJNOWXT7>K*NFK;4&4/OFL0DE?-7=%;WJA]DKQQ.]V
M\W@1S,<+=BZ5HY(?\VT#Z ZE<1@P-).KLA1\[ 6%CY),$T1B-PTH7<SE)=;H
M'7&)1'$.A/81#4F:KARC?F:\KEMXHY.0?!UP.!EX<;BQTF+PQU!6;&7]HIPZ
MRX3/&97/3HJ![;GL!_#+M8&Z?\[0]ZA2FJ"EB/\U%,CB0, 3+G%*]V,B*UZN
MIE[E$J>\2*3S-72G+<V9=E482\^7.F<]V1FTQNU&OR_@A<]!]_C+[8M$0O?X
M2-2=N@#;2>=<$K"U&T>3[ED>&@S%?-I[)_V377&1R.U4:5-79$G7L$I5$VM$
M-[&M2#8V;,LW#9DI%E<K6R+A""3I,(OI^28:D@1=D'#$T;^EJB2CH;A.H_\C
MF=1K)F#K%DQ[0ADJC51AH]X$: 4!NK7W8YB2IEBF@C53@_]D3\.V:BG8UQ6/
M4VY(,C$K6\Z>^_<#]GV>5BY^$7?AQ>S2[+AZ<3CS]KZK<%%>_9;K\XG=K<1Q
M7=<45:,@<39E('NZ@CV5J]BR;8E2C^G$L(5/F#+R#]H+8X^$Z)"'G&;((<DY
MSU;-)+^S6?$:PX"EO*G&E;BMLMERM]5SSVVGS^EY'C,BPV$2#Y- I+=[\1AY
M/(PO1=!-%(I8'++P7\@/0K'B"E(4B)L2&6<B")4&@U&8D8C'HS2<H)1D0>I/
M\I9E@]@#.A89JV6,*KD^3PO:%QP<$DUF97X<PN"BG4B;"$0>=HHV4L[1'H]X
M IS6BJ#MJ A];5>5:@'NN_I2?)>Q+*%RE9E2?7GT/Z&./ 8%"102CN4H*K.%
MT[M*THOC$$0WC#,@^JO4DS]RI<.1?&KHIDEUGX.*$ZDEOBIA8AL>)M0W?(F9
MFFS*0@?8IJ:]OZW34(EEH-Q--,]%: ]&LZ"\IN@EKPLFOQ';%;>M;,@FVMD]
M0$#)*E1<'M'^Y3CY$-PC"HB*>@XH)]!0X1L;WV)CY91:E-B$4:PP2Z3)&A1;
M'O$P-Q39XLPCNCCGM8R-KU&,!B6.E_"PK!$L*S?8>.[*H"LFUJ1J4?.-CZ_X
M^'/"A386EW+F5[ )\YFT?5]L';_Q\QP_JZ>F+"DF-V7LR[J/-5U7,3&(B36F
MV(P13[5\OIR? =68WL#U:OI9UAC.M]%6XNZB[AM_+^/O5IJ.>/+&Y<NY7#N5
M)2Y1G1-LFH8-SH<E8Z(1'\NJXC//T+E'U4?G<A5\G0VZ&I>7=>]R^4J+G+L;
MR#>$0K\E%.*BPQ<2BE8D#HZ(A<\$T7Q%!'">H\L^SP_YWEJNP.('0 2,BZGT
M4"^)+[.^P/U0+&%(BACW88C\:B"!=J1)^FQE<\OI*Z[84]&&((WY/O?]9I5A
M&*#*4%PL)-(A\IYDQ</*@KX6W=MWU:F@XW6[&]U6T8,I]T*$:BY!^E/F>169
MSK.1]_*!=XIQWS3:+8VFGRHJ5VV5Z=A33;#6AF9BSY X-G1%EBEGL)PREFJT
MUZ](_&^H!I&ZNE#/!'<B(GW0(GDL#;1(%.<*?)3RO!9,M(R[B!=E!'D$I+BR
M7#!C/E8X$8/G+V 1PA'!W* DX1=!"NU -Y&("@^?4"KN21*5Q>M"&$E86D1<
MV+(L(W6#7&49W50Z5830%5&7$/'FY>;#N "]GO"0B(3N.]>=7Z<LY327KIL0
M+XW#47:WR?=N2+_W->W2U3WM_:O$FR'I<>PEG)QCXH,6K9/PDDS22NVQ+W-_
M/:E;LEY5E<<_X6PI5<U<[=ZWI[A)[252+%H9'R"K*C*9'_LLWLM-JK@II2EN
MMTVK<QQ_$YHG/ 4U)V3?.R3QC"9#%C+3CM"=^V(WD4-H$N]Q\.7337%%2Q6\
M3EA.,41 08MC,: W.0&30*((=#@5.ESH9"@, U ^HC>H-PJSM'C]ECA! 7H[
MR$3D_H*G61F.%X&>8,@%7&@0@\D!-Q.H]"0'*925$(*>Z1C'XM$[8OMA%(8H
M?SM*:>GF42[\_RPC8,#SS8_<I=X9)8E8@17IR"(IZFK+A CWO!]X089 Q<I
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MOG:;W8KVEVO]O;. 7K#>ZNG@%U!+ P04    " "/D4U6"&8;1$0*   870
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MC@D/B.P^#38LCTULC^ \C:Z[VIIT'9:;,PE'UEM'_ZT$9_3527%-2X-)SNC
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M:6UI;F%R>7)E<W4N:'1M4$L! A0#%     @ CY%-5F6UF6$^%   ,8@  !$
M             ( !2A0  &UG;G@M,C R,S R,3,N:'1M4$L! A0#%     @
MCY%-5L] $K%K @  :P<  !$              ( !MR@  &UG;G@M,C R,S R
M,3,N>'-D4$L! A0#%     @ CY%-5@AF&T1$"@  &%T  !4
M ( !42L  &UG;G@M,C R,S R,3-?;&%B+GAM;%!+ 0(4 Q0    ( (^135:F
M%%N^QP8  *(Q   5              "  <@U  !M9VYX+3(P,C,P,C$S7W!R
;92YX;6Q02P4&      4 !0!0 0  PCP

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
